Homocysteine Reduction
Updated: 01/25/2006
References
Al-Obaidi MK, Stubbs PJ, et al. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol. 2000 Oct;36(4):1217-1222.
Anderson JL, Jensen KR, et al. Effect of folic acid fortification of food on homocysteine-related mortality. Am J Med. 2004 Feb 1;116(3):158-164.
Anderson JL, Muhlestein JB, et al. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation. 2000 Sep 12;102(11):1227-1232.
Carlsen SM, Folling I, et al. Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease. Scand J Clin Lab Invest. 1997 Oct;57(6):521-527.
Charlton CG, Mack J. Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain: support for an excess methylation hypothesis for parkinsonism. Mol Neurobiol. 1994 Aug-Dec; 9(1-3):149-161.
De Bree A, Verschuren WM, et al. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002 Dec;54(4)599-618.
de la Vega MJ, Santolaria F, et al. High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). Alcohol. 2001 Oct;25(2):59-67.
Devlin TM. Textbook of Biochemistry with Clinical Correlations . 5th ed. New York , NY : Wiley-Liss; 2001.
Dierkes J, Westphal S, et al. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet. 1999 Jul 17;354(9174):219-220.
Dudman NP, Guo XW, et al. Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease. J Nutr. 1996 Apr;126(suppl 4):1295S-1300S.
Fava M, Borus JS, et al. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry. 1997 Mar;154(3):426-428.
Finkelstein JD, Martin JJ. Methionine metabolism in mammals: distribution of homocysteine between competing pathways. J Biol Chem. 1984 Aug 10;259(15):9508-9513.
Friedman AN, Bostom AG, et al. The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001 Oct;12(10):2181-2189.
Garg R, Malinow M, et al. Niacin treatment increases plasma homocyst(e)ine levels. Am Heart J. 1999 Dec;138(6 pt 1):1082-1087.
Goren JL, Stoll AL, et al. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy. 2004 Nov;24(11):1501-1507.
Haagsma CJ, Blom HJ, et al. Influence of sulfasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis. 1999 Feb;58(2):79-84.
Harker LA, Ross R, et al. Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976 Sep;58(3):731-741.
Hvas AM, Juul S, et al. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom. 2004 Nov-Dec;73(6):340-343.
Jacques PF, Selhub J, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999 May 13;340(19):1449-1454.
Jakubowski H. Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans. Clin Chem Lab Med. 2003 Nov;41(11):1462-1466.
Joosten E, Lesaffre E, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol A Biol Sci Med Sci. 1997 Mar;52(2):M76-M79.
Lamango NS , Charlton CG. Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. Pharmacol Biochem Behav. 2000 Aug;66(4):841-849.
Lee H, Kim JH, et al. Creatine synthesis and transport systems in the male rat reproductive tract. Biol Reprod. 1998 Jun;58(6):1437-1444.
Life Extension Foundation. Anti-Aging News. Hollywood , Fla : Life Extension Foundation, November 1981;85-86.
Lombardo F, Sgro P, et al. Might erectile dysfunction be due to the thermolabile variant of methylenetetrahydrofolate reductase? J Endocrinol Invest. 2004 Oct;27(9):883-885.
Malinow MR, Bostom AG, et al. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999 Jan 5-12;99(1):178-182.
Martinez-Chantar ML, Garcia-Trevijano ER, et al. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr. 2002 Nov;76(5):1177S-1182S.
Matetzky S, Freimark D, et al. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction. Arch Intern Med. 2003 Sep 8;163(16):1933-1937.
McCaddon A, Davies G, et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998 Apr;13(4):235-239.
McCully KS . Homocysteine and vascular disease. Nat Med. 1996 Apr;2(4):386-389.
McKay DL, Perrone G, et al. Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet. J Nutr. 2000 Dec;130(12):3090-3096.
Morris MS, Bostom AG, et al. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis. 2001 Mar;155(1):195-200.
Muller T, Werne B, et al. Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet. 1999 Jul 10;345(9173):126-127.
Neal B, MacMahon S, et al. Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. Eur Heart J. 2002 Oct;23(19):1509-1515.
Nygard O, Nordrehaug JE, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997 Jul 24;337(4):230-236.
Oakley GP Jr. Eat right and take a multivitamin. N Engl J Med. 1998 Apr 9;338(15):1060-1061.
Ramos MI, Allen LH, et al. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr. 2004 Oct;80(4):1024-1028.
Righetti M, Tommasi A, et al. Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients. Perit Dial Int. 2004 Jul-Aug;24(4):373-377.
Schnyder G, Flammer Y, et al. Plasma homocysteine levels and late outcome after coronary angioplasty. J Am Coll Cardiol. 2002 Nov 20;40(10):1769-1776.
Schwaninger MC, Ringleb P, et al. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia. 1999 Mar;40(3):345-350.
Silveri MM, Parow AM, et al. S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biol Psychiatry. 2003 Oct 15;54(8):833-839.
Spence JD, Howard VJ, et al. Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology. 2001 Feb;20(1):16-25.
Stampfer MJ, Malinow MR, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992 Aug 19;268(7):877-881.
Stead LM, Au KP, et al. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E1095-E1100.
Stuhlinger MC, Tsao PS, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001 Nov 20;104(21): 2569-2575.
Tucker KL, Mahnken B, et al. Folic acid fortification of the food supply: potential benefits and risks for the elderly population. JAMA. 1996 Dec 18;276(23):1879-1885.
Vasan RS, Beiser A, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA. 2003 Mar 12;289(10):1251-1257.
Venn BJ, Mann JI, et al. Dietary counseling to increase natural folate intake: a randomized, placebo-controlled trial in free-living subjects to assess effects on serum folate and plasma total homocysteine. Am J Clin Nutr. 2002 Oct;76(4):758-765.
Ventura P, Rosa MC, et al. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics. Liver Int. 2005 Feb;25(1):49-56.
Verhoef P, Stampfer MJ, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996 May 1;143(9):845-859.
Vermeer SE, Hollander M, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan study. Stroke. 2003 May;34(5):1126-1129.
Vine AK . Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol. 2000 May;129(5):640-644.